Singular Genomics Systems Inc
NASDAQ:OMIC
Income Statement
Earnings Waterfall
Singular Genomics Systems Inc
Income Statement
Singular Genomics Systems Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
2
+112%
|
2
+31%
|
3
+21%
|
3
+12%
|
2
-14%
|
3
+9%
|
3
-2%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-140%
|
(1)
-365%
|
(1)
-86%
|
(1)
-8%
|
(1)
-21%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(28)
|
(32)
|
(40)
|
(49)
|
(61)
|
(73)
|
(83)
|
(91)
|
(93)
|
(97)
|
(98)
|
(100)
|
(100)
|
(103)
|
(98)
|
(92)
|
|
| Selling, General & Administrative |
(6)
|
(9)
|
(13)
|
(20)
|
(29)
|
(36)
|
(42)
|
(46)
|
(47)
|
(49)
|
(50)
|
(51)
|
(53)
|
(54)
|
(53)
|
(48)
|
|
| Research & Development |
(21)
|
(24)
|
(26)
|
(29)
|
(33)
|
(37)
|
(41)
|
(45)
|
(46)
|
(48)
|
(48)
|
(47)
|
(48)
|
(47)
|
(45)
|
(43)
|
|
| Operating Income |
(28)
N/A
|
(32)
-18%
|
(40)
-22%
|
(49)
-25%
|
(61)
-25%
|
(73)
-19%
|
(83)
-14%
|
(91)
-9%
|
(93)
-3%
|
(97)
-4%
|
(98)
-2%
|
(100)
-2%
|
(101)
-1%
|
(104)
-3%
|
(99)
+5%
|
(93)
+7%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
(12)
|
(35)
|
(35)
|
(36)
|
(24)
|
0
|
1
|
3
|
4
|
6
|
7
|
8
|
8
|
8
|
7
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(28)
N/A
|
(47)
-67%
|
(77)
-66%
|
(87)
-13%
|
(99)
-14%
|
(97)
+2%
|
(83)
+14%
|
(90)
-7%
|
(91)
-1%
|
(93)
-2%
|
(94)
-2%
|
(93)
+2%
|
(95)
-2%
|
(96)
-1%
|
(92)
+4%
|
(86)
+6%
|
|
| Net Income | |||||||||||||||||
| Income from Continuing Operations |
(28)
|
(47)
|
(77)
|
(87)
|
(99)
|
(97)
|
(83)
|
(90)
|
(91)
|
(93)
|
(94)
|
(93)
|
(95)
|
(96)
|
(92)
|
(86)
|
|
| Net Income (Common) |
(28)
N/A
|
(47)
-67%
|
(77)
-66%
|
(87)
-13%
|
(99)
-14%
|
(97)
+2%
|
(83)
+14%
|
(90)
-7%
|
(91)
-1%
|
(93)
-2%
|
(94)
-2%
|
(93)
+2%
|
(95)
-2%
|
(96)
-1%
|
(92)
+4%
|
(86)
+6%
|
|
| EPS (Diluted) |
-0.4
N/A
|
-0.66
-65%
|
-1.08
-64%
|
-1.22
-13%
|
-2.1
-72%
|
-1.35
+36%
|
-1.17
+13%
|
-1.25
-7%
|
-1.28
-2%
|
-1.29
-1%
|
-1.3
-1%
|
-1.28
+2%
|
-39.08
-2 953%
|
-39.04
+0%
|
-37.04
+5%
|
-34.51
+7%
|
|